☰

Kokomodo

Updating the operating model

Industry
Biotechnology
Public information as of
January 2026

A4BEE prepared this analysis from publicly available sources. It reflects our own reading of Kokomodo's published strategy and is not endorsed by, or produced in cooperation with, Kokomodo. Company website

Strategic priorities

Kokomodo operates across 4 stated priorities, with the most concrete near-term plan anchored on industrial-scale biomanufacturing.

Designing and deploying the Production N System with 10,000 PluriMatrix chambers to achieve 84,000kg wet biomass output, transitioning from laboratory-scale to continuous commercial production of cell-cultivated cacao.

Securing FDA GRAS approval for cell-cultivated cacao by 2026 and navigating EFSA novel food regulations to open North American and European markets simultaneously.

Validating functional cacao at industrial scale through strategic partnerships with Cargill and Chocolats Halba (Coop Switzerland), establishing credibility as a reliable ingredient supplier for global confectionery brands.

Challenges we see

  • Operations Manufacturing

    Bioreactor Scale-Up from Lab to 10,000 Chambers

    Kokomodo must scale from 5-liter laboratory bioreactors to a massive Production N System housing 10,000 PluriMatrix chambers operating simultaneously, requiring unprecedented control over fluid dynamics, oxygenation, and nutrient distribution across packed-bed 3D scaffolds.

    Without predictive modeling and real-time sensor analytics, localized dead zones or nutrient depletion within the 10,000 chambers will cause cascading batch failures and severe financial losses during a period of existential financial pressure.

  • Digital Integration

    Fragmented Data Environments Across R&D and Production

    Managing 14 distinct cacao cell lines with specific phenotypic traits requires smooth translation of biological parameters from disparate ELNs and unstructured spreadsheets in R&D labs to Manufacturing Execution Systems on the production floor.

    Where data is not harmonized between Tel Aviv R&D hubs and the Haifa GMP facility, phenotypic drift during scale-up, loss of targeted sensory profiles, and weakened batch-to-batch consistency can directly jeopardize the Cargill validation timeline.

  • Compliance Regulatory

    FDA GRAS and EFSA Regulatory Data Integrity

    FDA submissions for novel cell-cultured foods require exhaustive, immutable datasets proving genetic stability of cell lines over multiple generations, absolute safety of growth media, and absence of contamination, while maintaining 21 CFR Part 11 compliant audit trails.

    Paper-based quality processes, manual data entry, and siloed digital records across fragmented systems will inevitably trigger regulatory queries, delays, or outright rejection of the critical 2026 GRAS filing, blocking North American market access.

  • Digital Manufacturing

    IT/OT Convergence in GMP Manufacturing

    The Haifa GMP facility must achieve smooth convergence between OT systems (PLCs, SCADA, IoT sensors on bioreactors) and IT systems (LIMS, QMS, ERP) to deliver on the PluriCDMO promise of low batch-to-batch variability for both internal AgTech projects and external CDMO clients.

    Disconnected IT and OT systems lead to delayed batch release times, manual data transcription errors, and weakened quality assurance, eroding both Kokomodo's functional cacao consistency and PluriCDMO's competitive positioning in the contract manufacturing market.

  • Operations Energy

    Extreme Financial Pressure and Operational Cost Optimization

    Pluri Inc. reported a $23.25M net loss with a $443M accumulated deficit and faces a $23.5M EIB loan maturity in June 2026, forcing the need for extreme operational efficiency in the 47,000 sq ft Haifa GMP facility where energy costs for HVAC, bioreactor agitation, and cleanroom operations are major cost drivers.

    Without predictive maintenance and automated energy optimization, unplanned equipment downtime and inefficient OPEX will accelerate cash burn during the critical commercialization window, threatening the company's ability to service debt obligations and sustain operations.

Opportunities, by urgency and business impact

Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.

Source: A4BEE analysis of public sources

  1. Lab-to-Production Data Harmonization

    Kokomodo manages 14 distinct cacao cell lines across disparate R&D environments (Tel Aviv) and manufacturing (Haifa), with biological recipes siloed in ELNs and spreadsheets that cannot smooth translate into automated machine parameters on the production floor.

    Deploy an integrated ELN/LIMS/MES ecosystem that automatically translates R&D cell line recipes into validated production parameters, ensuring phenotypic consistency across all 14 cell lines during scale-up and eliminating manual transcription errors.

  2. Digital Twin for Bioreactor Scale-Up Simulation

    The proposed 10,000-chamber Production N System requires understanding complex fluid dynamics, mass transfer, and shear stress behavior at massive scale, yet there is no evidence of advanced physics-based or AI-driven digital twins being used to simulate these critical parameters before committing to physical prototyping.

    Build computational fluid dynamics (CFD) and mass-transfer digital twins of the PluriMatrix scaffold to simulate nutrient flow, cell shear stress, and temperature gradients in silico, optimizing bioreactor geometry and PLC control parameters before expensive physical runs.

  3. Automated Regulatory Compliance Architecture

    The 2026 FDA GRAS filing requires immutable, traceable datasets covering cell line genetic stability, growth media safety, and absence of contamination across multiple production generations, but current fragmented systems cannot produce 21 CFR Part 11 compliant electronic batch records automatically.

    Deploy a centralized, compliant data lake that automatically ingests telemetry from bioreactor IoT sensors, generating immutable Electronic Batch Records (EBR) with complete audit trails ready for FDA submission without manual data collation.

  4. Smart Factory IoT for Predictive Maintenance

    The Haifa GMP facility operates under extreme financial pressure with a $23.5M debt overhang, yet critical infrastructure (HVAC, cryo-freezers, bioreactor pumps) lacks advanced edge-computing IoT for predictive failure detection, risking unplanned downtime during high-value Cargill validation runs or external CDMO client batches.

    Install edge-computing IoT architecture across the GMP facility to enable predictive maintenance on critical infrastructure, minimize unexpected downtime, maximize facility utilization, and reduce energy consumption through automated HVAC and bioreactor agitation optimization.

  5. ESG Supply Chain Traceability and Reporting

    Kokomodo's core value proposition of deforestation-free cacao requires transparent, digitally verifiable chain of custody documentation for enterprise partners like Cargill and Coop Switzerland, yet there is no automated system to track batches from cell line isolation through energy consumption to final biomass harvest with Scope 1/2 ESG metrics.

    Develop a secure cloud traceability ledger that tracks each batch from specific cell line origin through PluriMatrix energy consumption to final harvest, providing automated ESG reporting dashboards that satisfy EU deforestation regulations and enterprise buyer sustainability requirements.

What we'd propose

  • Digital Lab

    Integrated Lab-to-Manufacturing Data Platform

    Deploy a unified data ecosystem connecting R&D Electronic Lab Notebooks with production-floor Manufacturing Execution Systems, enabling automated translation of cell line recipes into validated bioreactor parameters across Kokomodo's 14 cacao cell lines.

    • Unified data backbone

      Connect instruments and LIMS into a single data spine so QC and CDMO records are queryable across sites.

      DETAIL

    • Paperless workflows

      Move lab execution from paper to instrument-captured records with full audit trail.

      DETAIL

    • Continuous QC release

      Review-by-exception dashboards that flag only the records needing scientist attention.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital Lab
  • Digital CDMO

    Bioreactor Digital Twin and Process Simulation

    Develop physics-based and AI-driven digital twin models of the PluriMatrix scaffold system to simulate nutrient flow, shear stress, and temperature gradients within the proposed 10,000-chamber Production N System before physical prototyping.

    • OT/IT convergence

      Pull sensor and controller data off the line into a shared data plane in real time.

      DETAIL

    • Batch intelligence

      Golden-batch comparison and deviation detection running on the same data plane.

      DETAIL

    • Production release flow

      Closed-loop between QA, MES, and ERP so batch record review and release follow the data, not the paperwork.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital CDMO
  • Digital Lab

    GxP-Compliant Data Lake and Electronic Batch Records

    Architect and deploy a centralized, 21 CFR Part 11 compliant data infrastructure that automatically ingests bioreactor telemetry, analytical results, and quality data to generate immutable Electronic Batch Records for FDA GRAS and EFSA submissions.

    • Unified data backbone

      Connect instruments and LIMS into a single data spine so QC and CDMO records are queryable across sites.

      DETAIL

    • Paperless workflows

      Move lab execution from paper to instrument-captured records with full audit trail.

      DETAIL

    • Continuous QC release

      Review-by-exception dashboards that flag only the records needing scientist attention.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital Lab
  • Enterprise AI

    Smart Factory Predictive Maintenance and Energy Optimization

    Deploy edge-computing IoT architecture across the Haifa GMP facility to enable condition-based predictive maintenance on critical biomanufacturing infrastructure and optimize energy consumption across cleanroom HVAC, bioreactor agitation, and cryopreservation systems.

    • Ontology layer

      A shared semantic model so lab, process, and quality data describe the same things the same way.

      DETAIL

    • Predictive models

      Models trained on the historical data plane that flag deviations before they become scrap.

      DETAIL

    • Decision surfaces

      Single pane of glass that surfaces model output to the right role at the right moment.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Enterprise AI
  • Enterprise AI

    ESG Traceability Ledger and Sustainability Reporting

    Build a secure, cloud-based supply chain traceability platform that documents the complete provenance of each cell-cultivated cacao batch from cell line origin through biomanufacturing to final product, with automated ESG reporting for enterprise partners and EU regulatory compliance.

    • Ontology layer

      A shared semantic model so lab, process, and quality data describe the same things the same way.

      DETAIL

    • Predictive models

      Models trained on the historical data plane that flag deviations before they become scrap.

      DETAIL

    • Decision surfaces

      Single pane of glass that surfaces model output to the right role at the right moment.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Enterprise AI

Digital maturity: today and target

Scored out of 100 across six dimensions. The target is what Kokomodo's own published ambition implies — not a perfect score.

Source: A4BEE analysis of public sources
Data Integration & Interoperability 25 → 80
R&D data siloed in ELNs and spreadsheets across Tel Aviv and Haifa sites, with no automated bridge to production MES systems; 14 cell lines managed without unified data orchestration.
Process Automation & Control 35 → 85
PluriMatrix platform provides basic automated cell expansion but lacks closed-loop AI-driven control, real-time adaptive process optimization, and digital twin integration for the Production N System.
Regulatory Data Compliance 20 → 90
No evidence of 21 CFR Part 11 compliant electronic batch records or automated audit trails; FDA GRAS filing in 2026 requires immutable data infrastructure not yet in place.
Predictive Analytics & AI 15 → 75
No public evidence of predictive maintenance, AI-driven recipe optimization, or machine learning models for bioreactor process control despite managing 14 complex cell line recipes.
IT/OT Convergence 30 → 85
GMP facility has bioreactor PLCs and SCADA but lacks seamless integration with LIMS, QMS, and ERP systems; FreezOnTime cold chain logistics operating without unified IoT tracking platform.
Sustainability & ESG Digitalization 20 → 80
Deforestation-free value proposition is central to commercial strategy but lacks automated digital traceability, quantified environmental impact reporting, and Scope 1/2 emissions tracking.

Check this yourself

Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.

Think we've read this right?

Talk to us

Related reading

This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with Kokomodo, and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].